Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1133903]Brief description Osteoarthritis(OA) is a major contributor to this disease burden. Currently, there is no therapy that slows disease progression. Metformin may affect OA progression via multiple pathways that address the pathogenesis of knee OA, including weight loss, glucose- and lipid-lowering, and anti-inflammation. This will be the world first randomised, double-blind controlled trial, to assess the effect of metformin, compared with placebo, on knee OA-related structural and clinical outcomes
Funding Amount $AUD 128,225.21
Funding Scheme Postgraduate Scholarships
Notes Medical/Dental Postgraduate Scholarship
- nhmrc : 1133903
- PURL : https://purl.org/au-research/grants/nhmrc/1133903
